LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Penumbra Inc

Cerrado

SectorSalud

338.48 -0.53

Resumen

Variación precio

24h

Actual

Mínimo

337.48

Máximo

340.45

Métricas clave

By Trading Economics

Ingresos

-176M

-130M

Ventas

31M

385M

P/B

Media del Sector

81.89

66.845

Margen de beneficio

-33.822

Empleados

4,700

EBITDA

13M

68M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+9.64% upside

Dividendos

By Dow Jones

Próximas Ganancias

22 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

122M

13B

Apertura anterior

339.01

Cierre anterior

338.48

Noticias sobre sentimiento de mercado

By Acuity

67%

33%

306 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Penumbra Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

15 ene 2026, 13:29 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 ene 2026, 12:35 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 ene 2026, 12:29 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

25 feb 2026, 18:02 UTC

Ganancias

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

25 feb 2026, 18:01 UTC

Ganancias

Penumbra 4Q Rev $385.4M >PEN

25 feb 2026, 18:01 UTC

Ganancias

Penumbra 4Q Adj EPS $1.18 >PEN

25 feb 2026, 18:01 UTC

Ganancias

Penumbra 4Q EPS $1.20 >PEN

24 ene 2026, 06:18 UTC

Adquisiciones, fusiones, absorciones

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

15 ene 2026, 14:37 UTC

Acciones populares

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 ene 2026, 13:45 UTC

Adquisiciones, fusiones, absorciones

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 ene 2026, 12:04 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 ene 2026, 12:03 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 ene 2026, 12:01 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 ene 2026, 12:00 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 ene 2026, 12:00 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Comparación entre iguales

Cambio de precio

Penumbra Inc Esperado

Precio Objetivo

By TipRanks

9.64% repunte

Estimación a 12 meses

Media 372.36 USD  9.64%

Máximo 374 USD

Mínimo 360 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Penumbra Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

15 ratings

3

Comprar

12

Mantener

0

Vender

Puntuación técnica

By Trading Central

288.28 / 292.9394Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

306 / 351 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat